Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC

Abstract Background Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic...

Full description

Bibliographic Details
Main Authors: Jiaqi Xu, Lujuan Wang, Na Yin, Anqi Chen, Junqi Yi, Jingqun Tang, Juanjuan Xiang
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14147